https://www.selleckchem.com/pr....oducts/phorbol-12-my
In patients with CF results are also contradictory, but the consensus states there is a small clinical benefit, especially for patients infected with P. aeruginosa. There was also no positive action of macrolides in patients with post-infectious bronchiolitis obliterans. Children with non-CF bronchiectasis seem to have clear benefits regarding the use of macrolides, which showed clinical advantages in parenchyma protection and lung function. The long-term use of macrolides should be limited to highly selected sit
Like
Comment
Share
